Mobile Site ›
Normal View

Test ID: T3
T3 (Triiodothyronine), Total, Serum

Secondary ID A test code used for billing and in test definitions created prior to November 2011

8613

NY State Approved Indicates the status of NY State approval and if the test is orderable for NY State clients.

Yes

Useful For Suggests clinical disorders or settings where the test may be helpful

Second-order testing for hyperthyroidism in patients with low thyroid stimulating hormone values and normal T4 levels

 

Diagnosis of T3 toxicosis

Testing Algorithm Delineates situation(s) when tests are added to the initial order. This includes reflex and additional tests.

See Thyroid Function Ordering Algorithm in Special Instructions.

Special Instructions and Forms Describes specimen collection and preparation information, test algorithms, and other information pertinent to test. Also includes pertinent information and consent forms to be used when requesting a particular test

Method Name A short description of the method used to perform the test

Immunoenzymatic Assay

Reporting Name A shorter/abbreviated version of the Published Name for a test; an abbreviated test name

T3 (Triiodothyronine), Total, S

Aliases Lists additional common names for a test, as an aid in searching

T3 (Triiodothyronine), Total Only, Serum (Order 8613 unless specified)
T3 Suppression
T3 Total, Serum
Thyroid Function Cascade ORDER 80683
Total T3, Serum
Triiodothyronine (ORDER 8613 if not specified)
Triiodothyronine (T3)
Triiodothyronine, Total T3

Specimen Type Describes the specimen type needed for testing

Serum

Specimen Required Defines the optimal specimen. This field describes the type of specimen required to perform the test and the preferred volume to complete testing. The volume allows automated processing, fastest throughput and, when indicated, repeat or reflex testing.

Container/Tube:

Preferred: Serum gel

Acceptable: Red top

Specimen Volume: 0.6 mL

Specimen Minimum Volume Defines the amount of specimen required to perform an assay once, including instrument and container dead space. Submitting the minimum specimen volume makes it impossible to repeat the test or perform confirmatory or perform reflex testing. In some situations, a minimum specimen volume may result in a QNS (quantity not sufficient) result, requiring a second specimen to be collected.

0.5 mL

Reject Due To Identifies specimen types and conditions that may cause the specimen to be rejected

Hemolysis

Mild OK; Gross reject

Lipemia

Mild OK; Gross OK

Icterus

NA

Other

NA

Specimen Stability Information Provides a description of the temperatures required to transport a specimen to the laboratory. Alternate acceptable temperature(s) are also included.

Specimen TypeTemperatureTime
SerumRefrigerated (preferred)7 days
 Frozen 90 days

Clinical Information Discusses physiology, pathophysiology, and general clinical aspects, as they relate to a laboratory test

Thyroid hormones regulate a number of developmental, metabolic, and neural activities throughout the body. The 2 main hormones secreted by the thyroid gland are thyroxine, which contains 4 atoms of iodine (Thyroxine [T4]), and triiodothyronine (T3). T3 is also produced by conversion (deiodination) of T4 in peripheral tissues. Circulating levels of T4 are much greater than T3 levels, but T3 is more metabolically active than T4, although its effect is briefer.

 

Thyroid hormones circulate primarily bound to carrier proteins (eg, thyroid-binding globulin [TBG], albumin); a small fraction circulates unbound (free). Only the free forms are metabolically active. While both T3 and T4 are bound to TBG, T3 is bound less firmly than T4. Total T3 consists of both the bound and unbound fractions.

 

In hyperthyroidism both T4 and T3 levels are usually elevated, but in a small subset of hyperthyroid patients only T3 is elevated (T3 toxicosis).

 

In hypothyroidism T4 and T3 levels are decreased. T3 levels are frequently low in sick or hospitalized euthyroid patients.

 

See Thyroid Function Ordering Algorithm in Special Instructions.

Reference Values Describes reference intervals and additional information for interpretation of test results. May include intervals based on age and sex when appropriate. Intervals are Mayo-derived, unless otherwise designated. If an interpretive report is provided, the reference value field will state this.

> or =1 year: 80-190 ng/dL

Interpretation Provides information to assist in interpretation of the test results

Triiodothyronine (T3) values >180 ng/dL in adults or >200 ng/dL in children are consistent with hyperthyroidism or increased thyroid hormone-binding proteins.

 

Abnormal levels (high or low) of thyroid hormone-binding proteins (primarily albumin and thyroid-binding globulin) may cause abnormal T3 concentrations in euthyroid patients.

Cautions Discusses conditions that may cause diagnostic confusion, including improper specimen collection and handling, inappropriate test selection, and interfering substances

Triiodothyronine (T3) is not a reliable marker for hypothyroidism.

 

T3 is not useful for general screening of the population without a clinical suspicion of hyperthyroidism.

 

Some patients who have been exposed to animal antigens, either in the environment or as part of treatment or imaging procedures, may have circulating antianimal antibodies present. These antibodies may interfere with the assay reagents to produce unreliable results.

Clinical Reference Provides recommendations for further in-depth reading of a clinical nature

1. Hay ID, Klee GG: Linking medical needs and performance goals: clinical and laboratory perspectives on thyroid disease. Clin Chem 1993;39:1519-1524

2. Klee GG: Clinical usage recommendations and analytic performance goals for total and free triiodothyronine measurements. Clin Chem 1996;42:155-159

Method Description Describes how the test is performed and provides a method-specific reference

The instrument used is a Beckman Coulter DXI 800. The Access Total triiodothyronine (T3) assay is a competitive-binding immunoenzymatic assay. Sample is added to reaction vessel with a stripping agent to dissociate T3 from the binding proteins. T3 in the sample competes with the T3 analogue coupled to biotin for anti-T3 alkaline phosphatase conjugate. Of the resulting antigen: antibody complexes, the T3 analogue:antibody complexes are bound to the streptavidin-coated solid phase. Separation in a magnetic field and washing removes the sample T3:antibody complexes and other materials not bound to the solid phase. The chemiluminescent substrate Lumi-Phos 530 is added to the vessel and light generated by the reaction is measured with a luminometer. The light production is inversely proportional to the concentration of total T3 in the sample. The amount of analyte in the sample is determined from a stored, multipoint calibration curve. (Package insert: Beckman Coulter Ireland Inc, Fullerton, CA, 2009)

Day(s) and Time(s) Test Performed Outlines the days and times the test is performed. This field reflects the day and time the sample must be in the testing laboratory to begin the testing process and includes any specimen preparation and processing time required before the test is performed. Some tests are listed as continuously performed, which means assays are performed several times during the day.

Monday through Friday 5 a.m. – 12 a.m., Saturday 6 a.m. – 6 p.m.

Analytic Time Defines the amount of time it takes the laboratory to setup and perform the test. This is defined in number of days. The shortest interval of time expressed is "same day/1 day," which means the results may be available the same day that the sample is received in the testing laboratory. One day means results are available 1 day after the sample is received in the laboratory.

Same day/1 day

Maximum Laboratory Time Defines the maximum time from specimen receipt at Mayo Medical Laboratories until the release of the test result

3 days

Specimen Retention Time Outlines the length of time after testing that a specimen is kept in the laboratory before it is discarded

14 days

Performing Laboratory Location The location of the laboratory that performs the test

Rochester

Test Classification Provides information regarding the medical device classification for laboratory test kits and reagents. Tests may be classified as cleared or approved by the US Food and Drug Administration (FDA) and used per manufacturer's instructions, or as products that do not undergo full FDA review and approval, and are then labeled as an Analyte Specific Reagent (ASR), Investigation Use Only (IUO) product, or a Research Use Only (RUO) product.

This test has been cleared or approved by the U.S. Food and Drug Administration and is used per manufacturer's instructions. Performance characteristics were verified by Mayo Clinic in a manner consistent with CLIA requirements.

CPT Code Information Provides guidance in determining the appropriate Current Procedural Terminology (CPT) code(s) information for each test or profile. The listed CPT codes reflect Mayo Medical Laboratories interpretation of CPT coding requirements. It is the responsibility of each laboratory to determine correct CPT codes to use for billing.

84480

LOINC® Code Information Provides guidance in determining the Logical Observation Identifiers Names and Codes (LOINC) values for the result codes returned for this test or profile.

Result IDReporting NameLOINC Code
T3T3 (Triiodothyronine), Total, S3053-6